Celebrity Inventors
Comic actor Danny Kaye received patent D166,807 for the co-design of "Blowout Toy or the Like". It's similar to one of those toys that unravels when you blow into at a birthday party except Kaye's has three blowouts going in different directions, not just one.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7914789 | HEMCM42 antibodies The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted prote... | 03/29/2011 |
| 7842293 | Compositions and methods using anti-CS1 antibodies to treat multiple myeloma The present disclosure provides methods for treating multiple myeloma comprising administering to a subject with multiple myeloma the anti-CS1 antibody HuLuc63 in combination with dexamethasone and, optionally, thalidomide. ... | 11/30/2010 |
| 7824678 | Antibodies against cancer antigen TMEFF2 and uses thereof Described herein are methods and compositions that can be used for diagnosis and treatment of cancer. ... | 11/02/2010 |
| 7807163 | Antibodies against GPR64 and uses thereof GPR64 antibody compositions are provided. These antibodies may be used for diagnosis or treatment of cancer, especially ovarian cancer, Ewing's sarcoma, uterine cancer, and other GPR64 expressing tumor types. ... | 10/05/2010 |
| 7785816 | Antibodies against cancer antigen TMEFF2 and uses thereof Described herein are methods and compositions that can be used for diagnosis and treatment of cancer. ... | 08/31/2010 |
| 7776585 | Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis The present invention provides chimeric and humanized antibodies that specifically recognize α5β1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptabl... | 08/17/2010 |
| 7732570 | Alteration of Fc-fusion protein serum half-lives by mutagenesis The present invention provides for a modified Fc-fusion protein in which at least one amino acid from the heavy chain constant region selected from the group consisting of amino acid residues 250, 314, and 428 is substituted with another amino acid which is differen... | 06/08/2010 |
| 7732195 | Tethered vectors for cell surface immunoglobulin display Disclosed are mammalian cell surface display vectors for isolating and/or characterizing immunoglobulins and various uses thereof. ... | 06/08/2010 |
| 7709610 | Therapeutic use of anti-CS1 antibodies The present invention is directed to antagonists of CS1 that bind to and neutralize at least one biological activity of CS1. The invention also includes a pharmaceutical composition comprising such antibodies or antigen-binding fragments thereof. The present inventi... | 05/04/2010 |
| 7674883 | Antibodies against cancer antigen TMEFF2 and uses thereof Described herein are methods and compositions that can be used for diagnosis and treatment of cancer. ... | 03/09/2010 |
| 7662384 | Use of anti-α5β1 antibodies to inhibit cancer cell proliferation The present invention provides methods for direct killing of cancer cells using anti-α5β1 antibodies. Generally, the method comprises contacting a cancer cell that expresses α5β1 on its surface with an anti-α5β1 antibody, and thereby inducing the death of the ... | 02/16/2010 |
| 7592004 | Stable lyophilized pharmaceutical formulation of IgG antibodies This invention is directed to a stable lyophilized pharmaceutical formulation prepared by lyophilizing an aqueous formulation comprising a high concentration, e.g. 50 mg/ml or more, of an IgG antibody in about 5-25 mM histidine buffer having pH from about 5.5 to abo... | 09/22/2009 |
| 7547544 | Antibodies against GPR64 and uses thereof GPR64 antibody compositions are provided. These antibodies may be used for diagnosis or treatment of cancer, especially ovarian cancer, Ewing's sarcoma, uterine cancer, and other GPR64 expressing tumor types. ... | 06/16/2009 |
